317_L27, Mar 19 2008 J. Schaafsma 1 Review of the Last Lecture Are looking at program evaluation in healthcare: CBA, CEA, CUA Finished our discussion of.

Slides:



Advertisements
Similar presentations
RESOURCE ALLOCATION & THE MARKET Demand, supply and the market Sources of failure in the market for health care The insurance system of funding health.
Advertisements

Chapter Twenty-Five Monopoly Behavior. How Should a Monopoly Price? u So far a monopoly has been thought of as a firm which has to sell its product at.
Chapter Twenty-Five Monopoly Behavior. How Should a Monopoly Price? u So far a monopoly has been thought of as a firm which has to sell its product at.
PERFECT COMPETITION Economics – Course Companion
Chapter 8 Welfare Economics and The Gains From Trade
Correcting Market Distortions: Shadow Prices, Shadow Wages and Discount Rates Chapter 6.
Equity, Efficiency and Need
Copyright © 2008 Pearson Addison-Wesley. All rights reserved. Chapter 10 Monopoly, Cartels, and Price Discrimination.
12 Prepared by: Fernando Quijano and Yvonn Quijano © 2004 Prentice Hall Business PublishingPrinciples of Economics, 7/eKarl Case, Ray Fair Monopoly.
MonopolyMonopoly Chapter 12. Introduction Monopoly is the polar opposite of perfect competition. Monopoly is a market structure in which a single firm.
General Equilibrium and Efficiency. General Equilibrium Analysis is the study of the simultaneous determination of prices and quantities in all relevant.
317_L23, Mar 7, 2008, J. Schaafsma 1 Review of the Last Lecture Began our discussion of the econ. evaluation of healthcare programs Will be looking at.
317_L28, Mar J. Schaafsma 1 Review of the Last Lecture Have finished our discussion of program evaluation in healthcare Began section VII(1): The.
317_L8, Jan 23, 2008, J. Schaafsma 1 Review of the Last Lecture Began our discussion of the demand for HC Demand for HC is a derived demand (demand for.
317_L31, April 1, 2008, J. Schaafsma 1 Review of the Last Lecture began our discussion of hospitals as firms Reviewed some basic hospital trends post WWII.
317_L3_Jan 11, Review of the Last Lecture Discussed the case for and against applying economic analysis to healthcare looked at a simple flow chart.
317_L5_Jan 16, 2008 J. Schaafsma 1 Review of the Last Lecture Are discussing the production function for health (section III of the course outline): HS=HS(HC)
317_L22, Mar 5, 2008, J. Schaafsma 1 Review of the Last Lecture Finished our discussion of information asymmetry as a source of market failure in the healthcare.
317_L24, Mar 11/08, J. Schaafsma 1 Review of the Last Lecture are discussing shadow pricing in the context of cost-benefit analysis noted that shadow pricing.
317_L13, Feb 5, 2008, J. Schaafsma 1 Review of the Last Lecture finished our discussion of the demand for healthcare today begin our discussion of market.
317_L30, Mar 28, 2008, J. Schaafsma 1 Review of the Last Lecture Are discussing three generations of models of the practitioner firm have finished our.
317_L21, Mar 4, 2008, J. Schaafsma 1 Review of the Last Lecture began our discussion of information asymmetry in the healthcare market Two aspects to the.
317_L12, Feb 1, 2008, J. Schaafsma 1 Review of the Last Lecture discussed the effect of proportional health insurance on the healthcare market => showed.
317_L6_Jan 18, 2008 J. Schaafsma 1 Review of the Last Lecture Are discussing the production of health: section III of the course outline have discussed.
317_L25, Mar J. Schaafsma 1 Review of the Last Lecture Have discussed three methods for shadow pricing life and limb for CBA: human capital method,
Departures from perfect competition
317_L29, March 26, 2008, J. Schaafsma 1 Review of the Last Lecture Began a discussion of 3 generations of models of the practitioner firm Almost finished.
COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS
317_L7_Jan 22, 2008 J. Schaafsma 1 Review of the Last Lecture Are discussing the production of health: section III of the course outline have discussed.
317_L10, Jan 29, 2008, J. Schaafsma 1 Review of the Last Lecture began our discussion of the demand function for healthcare Discussed: derived demand,
12 MONOPOLY CHAPTER.
Session 3 Monopoly Managerial Economics Professor Changqi Wu.
Chapter 11: Cost-Benefit Analysis Econ 330: Public Finance Dr
The Production Decision of a Monopoly Firm Alternative market structures: perfect competition monopolistic competition oligopoly monopoly.
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
Imperfect Competition and Market Power: Core Concepts Defining Industry Boundaries Barriers to Entry Price: The Fourth Decision Variable Price and Output.
 Firm that is sole seller of product without close substitutes  Price Maker not a Price Taker  There are barriers to entry thru: Monopoly Resources,
Copyright © 2004 South-Western Monopoly vs. Competition While a competitive firm is a price taker, a monopoly firm is a price maker. A firm is considered.
Monopoly ETP Economics 101. Monopoly  A firm is considered a monopoly if...  it is the sole seller of its product.  its product does not have close.
McGraw-Hill/Irwin © 2004 The McGraw-Hill Companies, Inc., All Rights Reserved. Monopoly Chapter 12.
Economic evaluation Definition - the comparative analysis of alternative courses of action in terms of both their cost and consequences.
McGraw-Hill/Irwin Copyright  2006 by The McGraw-Hill Companies, Inc. All rights reserved. MONOPOLY MONOPOLY Chapter 12.
317_L26, Mar J. Schaafsma 1 Review of the Last Lecture Are looking at program evaluation in healthcare Three methods: CBA, CEA, CUA discussed CBA,
Copyright © 2006 Thomson Learning 15 Monopoly. Figure 1 Economies of Scale as a Cause of Monopoly Copyright © 2004 South-Western Quantity of Output Average.
Monopoly and Oligopoly Announcements See web page for all exam information. Please get to exam rooms on time and have your CU ID ready to show the proctor.
Market Failure. Occurs when free market forces, using the price mechanism, fail to produce the products that people want, in the quantities they desire.
Modeling the Market Process: A Review of the Basics Chapter 2 © 2004 Thomson Learning/South-Western.
Chapter 12 Monopoly. Basic Definitions Imperfect Competition: Occurs when firms in a market or industry have some control over the price of their output.
MONOPOLIES.  Single seller (pure monopoly) – industry with only one dominant company  Cartel agreement – group of producers who enter a collusive agreement.
Monopoly. Intro video
Chapter 2: The Role of Economics
Monopoly & Efficiency Deadweight Loss Analysis. Allocative Efficiency Total Welfare is maximized only when MC = MB for society –Since MB = Price => only.
1.  exists when a single firm is the sole producer of a product for which there are no close substitutes. 2.
Monopoly 2 Bad things that monopolist do!. Laugher Curve The First Law of Economics: For every economist, there exists an equal and opposite economist.
Review Monopoly Summary A monopoly is a firm that is the sole seller in its market. It faces a downward-sloping demand curve for its product. A.
Market Failure. Occurs when free market forces, using the price mechanism, fail to produce the products that people want, in the quantities they desire.
And Unit 3 – Theory of the Firm. 1. single seller in the market. 2. a price searcher -- ability to set price 3. significant barriers to entry 4. possibility.
A P.O. Is a C.E. © 1998 by Peter Berck. What Is It Good? §Sum of surplus and profits allows for policies that make income less evenly distributed. §A.
Price Discrimination 1. Defined: Sellers engage in price discrimination when they charge different prices to different consumers for the same good, because.
Monopoly 15. Monopoly A firm is considered a monopoly if... it is the sole seller of its product. it is the sole seller of its product. its product does.
Efficiency and Equity in a Competitive Market
(normal profit= zero econ. profit)
Monopoly, Monopolistic Competition & Oligopoly
ENV 536: Environmental Economics and Policy (Lecture 3) Modeling the Market Process: A Review of the Basics Asst.Prof. Dr. Sasitorn Suwannathep School.
15 Monopoly.
Monopoly and Pricing.
Monopoly and Pricing.
Market Structures I: Monopoly
Deadweight Loss Analysis
Presentation transcript:

317_L27, Mar J. Schaafsma 1 Review of the Last Lecture Are looking at program evaluation in healthcare: CBA, CEA, CUA Finished our discussion of CBA and CEA Started our discussion of CUA (Cost Utility Analysis) In CUA the output measure is a QALY to compute a QALY need Health Related Quality of Life weights Three techniques for computing HRQoL weights: rating scale, Time- Trade-off, Standard Gamble. Have discussed the first two. Today: begin by looking at the Standard Gamble method Then discuss whether QALY’s should be discounted. Then begin section VII(1): Supply of Physician services

317_L27, Mar J. Schaafsma 2 Computing Utility Values: Standard Gamble: SG classical method of measuring cardinal utility based on work by von Neuman and Morgenstern (1953) SG  considers a choice between staying in the current state of chronic ill health for n years followed by death, or accepting what could be considered a lottery ticket. the lottery ticket consists of accepting treatment  one of two outcomes will occur: i) full health for n years then painless death, with a probability of p ii) instant painless death, with a probability of (1 – p) (diagram)

317_L27, Mar J. Schaafsma 3 SG Method Continued subject is confronted with the choice of staying in the chronic state of ill health or accepting the lottery ticket (treatment) obviously if ill health very bad and p of success very high  accept treatment at some value p e for the prob of successful treatment the person is indifferent between treatment (lottery ticket) and no treatment: i.e., U(HS ill ) = p e U(full health) + (1 – p e ) U(death) set U(death) = 0, then U(full health) = 1  U(HS ill ) = p e U(HS ill ) is the fraction, p e, of the utility of full health U(full health) NB. These fractions are additive  QALYs =  p e i i = 1,…,n ///

317_L27, Mar J. Schaafsma 4 Problems with the SG Method applying this technique to subjects experiencing the state of ill- health can be problematic (stressful for patients) applying this technique to subjects who are not ill requires them to understand the true extent of the state of ill health (also problematic) subjects may not be able to judge the true significance of different probability values.

317_L27, Mar J. Schaafsma 5 Discounting QALYs basic issue  is saving 10 lives at a given HRQoL for 1 year equivalent to saving 1 life for 10 years at the same HRQoL? really two issues here: 1.An equity issue: if we can save 10 QALY’s are we indifferent between saving 1Qaly for each of 10 people, or 10 QALY’s for 1 person (we will ignore this distributional issue) 2. whether QALYs that accrue in the future as a result of HC today should be discounted or not. ///

317_L27, Mar J. Schaafsma 6 Arguments Against Discounting QALYs discounting implies inter-temporal choice  ability to trade off future benefits for present ones and vice versa  at the individual level inter-temporal choice is feasible for quality of life but not for life years  can’t give up a life year now for more tomorrow  thus argued  don’t discount while an individual has a finite time horizon and thus discounts the future (may not be alive next year, or two years from now so present is more valuable than the uncertain future); society could be considered infinitely lived  thus no time preference  thus future as important as the present  no discounting. ///

317_L27, Mar J. Schaafsma 7 Arguments for Discounting QALYs the flow of HC costs over time is always discounted  symmetry requires that QALYs also be discounted  society unlikely to be indifferent between two projects with the same PV of HC costs and the same undiscounted QALYs gained but where the gain is far into the future for one project and the gain is immediate for the other.=> discounting QALYs takes care of this problem statistically can trade-off lives inter-temporally! HOW?  - borrow for expanded HC services today  save lives. - later when the debt must be serviced  curtail HC services to balance the budget  lives could be lost. ///

317_L27, Mar J. Schaafsma 8 VII. The Provision of Healthcare 1. Modeling the Supply of Physician Services the cost of physician services is the third largest component of the HC budget (about 13% compared to 40% for institutional care and 17% for drugs). Also: physicians are the gate keepers (determine the care patients receive, thus influence hospital expenditures). in Canada, physician services generally provided by the practitioner- firm on a fee-for-service basis (self-employed providers) practitioner firm is a physician’s practice  owned/operated by the HC practitioner  e.g., medical practice, dental practice, optometric practice, pharmacy (is there an ordering here from an economic perspective?)  strength of profit motive  going  the list? ///

317_L27, Mar J. Schaafsma 9 Attributes of the Practitioner Firm Similarities with the concept of the firm in standard micro theory: the practitioner firm (PF) combines inputs to produce an output output generally sold on a fee-for-service basis (price per unit) Differences from the firm in standard micro theory: owner is patient’s agent  thus not-only-for-profit firm owner supplies a large part of the labour input Question: how should the practitioner firm be modeled if we are to understand its factor input combination in production, output and pricing decisions in response to changes in the environment in which it operates? And allocative and technical efficiency ? ///

Allocative and Technical Efficiency 317_L27, Mar J. Schaafsma 10 Our discussion of the various models of the practitioner firm will focus on their implications for allocative and technical efficiency Allocative Efficiency exists if MB = MC (a higher output of a good results in a deadweight loss (MB MC) Technical Efficiency exists if the given quantity of output is being produced at the lowest possible cost

317_L27, Mar J. Schaafsma 11 Modeling the Practitioner Firm: the Case of Physicians. models of the physician firm have gone through three successive stages that emphasized different characteristics of these firms: 1. Monopoly models that stressed monopoly power conferred by self-regulation and licensure 2. Self-employed “labour managed” nature of the firm. 3.Information Asymmetry and SID Each model builds on the preceding one ///

317_L27, Mar J. Schaafsma 12 The Physician Firm as a Monopoly: Supply Restrictions in these models licensure restricts entry  confers monopoly power. however, NOTE that the power to license does not necessarily confer monopoly power. competing organizations could develop e.g. physicians vs. chiropractors lawyers vs. notaries in accounting  CA, CGA, CMA, CPA ///

317_L27, Mar J. Schaafsma 13 Licensure and Monopoly Power for licensure to restrict supply (create monopoly power) need: 1. Control over entry. 2. Effective boundaries on the set of activities only members of the licensed profession are allowed to supply (need not perform them  could hire non-licensed help and supervise them) 3.Control over the output by its members (If licensed professionals can easily expand supply by hiring non-licensed help  require that only a licensed professional may supply the service or restrict the number of employees a professional may supervise). ///

317_L27, Mar J. Schaafsma 14 Four Models Based on Restricted Supply and Monopoly Power will look at four models that stress restricted entry and monopoly power: 1. Competition behind the barrier to entry 2. Monopolistic competition 3. 1 st degree price discriminating monopolist 4. Cartel and joint profit maximization these 4 models assume: demand exogenous and profit maximization. ///

317_L27, Mar J. Schaafsma 15 Monopoly Model 1: Competition Behind the Barrier to Entry profession restricts entry practitioner firms compete behind barrier to entry (diagram) supply curve sits more to the left than if free entry consequences  welfare loss (consumer surplus and producer surplus components) & higher producer surplus to physicians who do get past the barrier at the expense of consumer surplus (diagram) allocative inefficiency Technical efficiency (guaranteed by competition and profit maximization)

317_L27, Mar J. Schaafsma 16 Possible Barriers to Entry excessively high grade requirement excessive educational requirements marginally relevant but very challenging courses (e.g. dissecting an entire human cadaver in an optometry program) high fees for board exams exceptionally difficult board exams ///